Osteoclastogenesis is an essential process during bone metabolism which can also be promoted by inflammatory signals. Thrombomodulin (TM), a transmembrane glycoprotein, exerts anti-inflammatory activities such as neutralization of proinflammatory high-mobility group box 1 (HMGB1) through TM lectin-like domain. This study aimed to identify the role of myeloid TM (i.e., endogenous TM expression on the myeloid lineage) in osteoclastogenesis and inflammatory bone loss. Using human peripheral blood mononuclear cells and mouse bone marrow-derived macrophages, we observed that the protein levels of TM were dramatically reduced as these cells differentiated into osteoclasts. In addition, osteoclastogenesis and extracellular HMGB1 accumulation were enhanced in primary cultured monocytes from myeloid-specific TM-deficient mice (LysMcre/TM(flox/flox)) and from TM lectin-like domain deleted mice (TM(LeD/LeD)) compared with their respective controls. Micro-computerized tomography scans showed that ovariectomy-induced bone loss was more pronounced in TM(LeD/LeD) mice compared with controls. Finally, the inhibiting effects of recombinant TM lectin-like domain (rTMD1) on bone resorption in vitro, and bone loss in both the ovariectomized model and collagen antibody-induced arthritis model has been detected. These findings suggested that the myeloid TM lectin-like domain may inhibit osteoclastogenesis by reducing HMGB1 signaling, and rTMD1 may hold therapeutic potential for inflammatory bone loss.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911607PMC
http://dx.doi.org/10.1038/srep28340DOI Listing

Publication Analysis

Top Keywords

lectin-like domain
20
bone loss
20
inflammatory bone
12
osteoclastogenesis inflammatory
8
bone
8
lectin-like
5
domain
5
osteoclastogenesis
5
loss
5
myeloid
4

Similar Publications

Understanding how membrane composition influences the dynamics and function of transmembrane proteins is crucial for the comprehensive elucidation of cellular signaling mechanisms and the development of targeted therapeutics. In this study, we employed all-atom molecular dynamics simulations to investigate the impact of different membrane compositions on the conformational dynamics of the NKG2A/CD94/HLA-E immune receptor complex, a key negative regulator of natural killer cell cytotoxic activity. Our results reveal significant variations in the behavior of the immune complex structure across five different membrane compositions, which include POPC, POPA, DPPC, and DLPC phospholipids, and a mixed POPC/cholesterol system.

View Article and Find Full Text PDF

The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity.

EMBO Rep

December 2024

Medical Research Council (MRC) Centre for Medical Mycology, University of Exeter, Exeter, UK.

Article Synopsis
  • Myeloid cells use transmembrane protein receptors to identify and distinguish between different types of ligands, playing a vital role in immune responses.
  • C-type lectin receptors (CLRs), particularly Dectin-1 and Dectin-2, have a key structural motif called the C-type lectin-like domain (CTLD) that allows them to recognize a variety of biological molecules, including glycans, proteins, and lipids.
  • This review focuses on the latest findings related to the expression, signaling pathways, and immune functions of Dectin clusters, emphasizing their critical roles in immune cell activity.
View Article and Find Full Text PDF

NKG2D chimeric antigen receptor (CAR)-modified T cells (NKG2D CAR-T cells) have been reported to be preclinically efficient in several tumors, but little is known whether NKG2D CAR-T cells co-expressing IL21 (IL21-NKG2D CAR-T cells) display greater antitumor activity in multiple myeloma (MM). In this study, the lentivirus has been produced for expression of the IL21 sequence linked to the extracellular NKG2D sequence with the signal peptide linked through the CD8α hinge-transmembrane domain to the 4-1BB molecule fused with the CD3-ζ chain signaling domain, and the engineered IL21-NKG2D CAR-T cells and NKG2D CAR-T cells were constructed. The CAR expression on CAR-T cells was assessed by flow cytometry, and the killing effects of CAR-T cells on MM were assessed by the cytotoxicity assay and ELISA assay.

View Article and Find Full Text PDF
Article Synopsis
  • NKG2D is a receptor on immune cells that helps target and eliminate cancer cells by recognizing specific ligands, leading to the development of bispecific antibodies that redirect immune cells to cancer cells with the ErbB2 (HER2) antigen.
  • Researchers created cross-reactive scFv antibodies by immunizing chickens and screening a yeast library, resulting in four new antibodies reformatted into bispecific engagers (scNKAB-ErbB2) that bind to both ErbB2-positive cancer cells and NKG2D-expressing immune cells.
  • All four tested scNKAB-ErbB2 antibodies demonstrated effectiveness in activating immune cells against cancer targets, indicating their potential for further development in cancer immunotherapy.
View Article and Find Full Text PDF

A unique Ca-inhibited C-type lectin in shrimp Fenneropenaeuschinensis.

Fish Shellfish Immunol

July 2024

Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou, 511458, China; MOE Key Laboratory of Marine Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao, 266003, China; Key Laboratory of Tropical Aquatic Germplasm of Hainan Province, Sanya Oceanographic Institution, Ocean University of China, Sanya, 572024, China. Electronic address:

C-type lectins (CTLs) are glycan-binding pattern recognition receptors (PRRs) that can bind to carbohydrates on pathogen surfaces, triggering immune responses in shrimp innate immunity. In this study, a unique Ca-inhibited CTL named FcLec was identified and characterized in Chinese shrimp Fenneropenaeus chinensis. The full-length cDNA sequence of FcLec was 976 bp (GenBank accession number KU361826), with a 615 bp open reading frame (ORF) encoding 204 amino acids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!